Stock:
Symbol Lookup
Register | Login
...
History
...
...

Pre Market | Dow Jones | Gold | Newsletters | Learn


Big Moving Stocks for Jan-7 Afternoon

Tuesday, January 7, 2014 1:11 PM

These stocks are posting some big moves for today.

Neurocrine Biosciences Inc. (NBIX) is currently trading at $17.84 + 8.08 (82.79%) on 11,491,673 shares traded. Neurocrine Biosciences Inc. is +91.01% year-to-date, and +114.56% over the last 12 months.

Neurocrine Biosciences, Inc., discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders.

Epizyme Inc. (EPZM) is currently trading at $34.18 + 13.68 (66.73%) on 2,287,265 shares traded. Epizyme Inc. is +64.33% year-to-date, and -- over the last 12 months.

Epizyme Inc is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

LiveDeal Inc. (LIVE) is currently trading at $7.89 + 2.19 (38.42%) on 682,834 shares traded. LiveDeal Inc. is +98.24% year-to-date, and +132.60% over the last 12 months.

LiveDeal, Inc.. provides marketing solutions that boost customer awareness and merchant visibility on the internet.

Plug Power Inc. (PLUG) is currently trading at $3.69 + 0.9199 (33.21%) on 51,171,700 shares traded. Plug Power Inc. is +138.06% year-to-date, and +662.25% over the last 12 months.

Plug Power Inc., is a provider of alternative energy technology focused on the design, development, commercialization and manufacture of fuel cell systems for the industrial off-road market.

Pharmacyclics Inc. (PCYC) is currently trading at $126.78 + 21.72 (20.67%) on 2,220,127 shares traded. Pharmacyclics Inc. is +19.85% year-to-date, and +95.94% over the last 12 months.

Pharmacyclics, Inc., is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

Pharmacyclics Inc. (PCYC) is currently trading at $125.47 + 20.41 (19.43%) on 2,547,688 shares traded. Pharmacyclics Inc. is +18.61% year-to-date, and +95.94% over the last 12 months.

Pharmacyclics, Inc., is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.

Stereotaxis Inc (STXS) is currently trading at $4.75 + 0.75 (18.75%) on 3,779,728 shares traded. Stereotaxis Inc is +31.22% year-to-date, and +65.86% over the last 12 months.

Stereotaxis, Inc. designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease.

Sevcon Inc. (SEV) is currently trading at $7.24 + 0.8455 (13.23%) on 43,577 shares traded. Sevcon Inc. is +8.64% year-to-date, and +95.41% over the last 12 months.

Sevcon Inc designs and sells, under the Sevcon name, microprocessor based controls for zero emission and hybrid electric vehicles.

Cray Inc. (CRAY) is currently trading at $30.34 + 3.18 (11.71%) on 1,202,010 shares traded. Cray Inc. is +10.49% year-to-date, and +82.38% over the last 12 months.

Cray Inc. designs, develops, and supports high-performance computer systems, commonly known as supercomputers and/or clusters, and provide storage solutions, software and engineering services related to HPC systems.

TheStreet, Inc. (TST) is currently trading at $2.44 + 0.239 (10.86%) on 68,862 shares traded. TheStreet, Inc. is +7.92% year-to-date, and +46.67% over the last 12 months.

TheStreet, Inc. is digital financial media company whose collection of digital services provides users, subscribers and advertisers with a variety of content and tools through a range of online, social media, tablet and mobile channels.

PRINT

FREE Options Trading Lessons
I'll show you how to unlock HUGE Gains with Options Trading
Let's make 2014 the year you get RICH!

Latest Headlines

'We don't have a magic wand', says ECB's Constancio'We don't have a magic wand', says ECB's Constancio
MADRID (Reuters) - Societies expect too much of central banks and they don`t have a magic wand to boost economic growth, European Central Bank Vice President Vitor Constancio said on Thursday. The E...
Politics clouds proposed overhaul of U.S. housing finance systemPolitics clouds proposed overhaul of U.S. housing finance system
WASHINGTON (Reuters) - The Senate Banking Committee appears likely to back a bill to wind down government-backed mortgage giants Fannie Mae and Freddie Mac, according to sources familiar with talks ...
April U.S. auto sales to rise 8.5 percent: J.D. Power, LMCApril U.S. auto sales to rise 8.5 percent: J.D. Power, LMC
DETROIT (Reuters) - U.S. auto sales will rise 8.5 percent in April from a year ago as spring weather entices consumers to look at new products, industry research firms J.D. Power and LMC Automotive sa...
Vivendi to return 5 billion euros to shareholders after asset salesVivendi to return 5 billion euros to shareholders after asset sales
PARIS (Reuters) - French conglomerate Vivendi <VIV.PA> said it would pay out close to 5 billion euros in dividends and buy backs this year and next, rewarding shareholders after three major as...
Google social networking boss Gundotra leaving companyGoogle social networking boss Gundotra leaving company
SAN FRANCISCO (Reuters) - Google Inc`s head of social networking services, Vic Gundotra, is leaving the Internet search company, he said on Thursday, three years after overseeing the launch of the G...

Loading Headlines...
 

Stock Market

Track the stock market today with the latest news and information on all things investing! Watch your stocks perform throughout the day and watch the breaking stock market news.

Feedback | disclaimer | privacy policy

Stock Market News

The Stock Market is ever changing. Keep up on your stock market news.

Stock Market Newsletters

Read up on your favorite stock market newsletters.


Learn the Stock Market

Sharper your stock trading skills with our stock market education section.